Dexamethasone, High-Dose Cytarabine, and Cisplatin in Combination with Rituximab as Salvage Treatment for Patients with Relapsed or Refractory Aggressive Non-Hodgkin's LymphomaUlrich Mey, Ingo G.H. Schmidt‐Wolf, Katjana Orlopp et al.|Cancer Investigation|2006Cited by 61
A Phase II Trial of Dexamethasone, High-Dose Cytarabine, and Cisplatin (DHAP) in Combination with Rituximab as Salvage Treatment for Patients with Refractory or Relapsed Aggressive Non-Hodgkin’s Lymphoma.Ulrich Mey, Ingo G.H. Schmidt‐Wolf, John Strehl et al.|Blood|2004Cited by 3
Safety and Efficacy Results from CLI120-001 a Phase 1 Study in RR-AML and HR-MDS: Update from Higher Dose LevelsEwa Lech‐Marańda, Jan Maciej Zaucha, Noemi Angelosanto et al.|Blood|2023Cited by 1